Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments

December 06, 2023 00:17:57
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments
COR2ED - Oncology Medical Conversation
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments

Dec 06 2023 | 00:17:57

/

Show Notes

In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité University of Medicine, Germany) discuss the different therapeutic options available in colorectal and gastric cancer.

In this third episode, the experts turn their focus to earlier stage disease and consider how lessons learnt in the treatment of metastatic disease can be applied in the neo adjuvant setting for colorectal cancer by discussing data from the FOXTROT and NICHE trials and the adjuvant setting for gastric cancer by discussing data from CheckMate 577. Finally, the experts consider new promising data on targeting KRAS compared to the MEK and the ERK inhibitors.

Other Episodes

Episode

April 25, 2024 00:27:48
Episode Cover

Cáncer de pulmón: dificultades en la fase preanalítica y pruebas de biomarcadores

¿Cuáles son los desafíos frecuentes en la fase preanalítica del cáncer de pulmón, y cómo podemos superarlos? ¿Por qué es importante identificar las alteraciones...

Listen

Episode

December 06, 2023 00:30:22
Episode Cover

HCC: Updates from ILCA and ESMO 2022

In this HCC CONNECT podcast HCC Experts Prof. Matthias Pinter and Prof. Jeroen Dekervel, discuss and debate the clinical implications of new HCC Phase...

Listen

Episode

December 07, 2023 00:22:35
Episode Cover

Precision oncology: An overview of tumour agnostic therapies

What are tumour agnostic cancer treatments and which biomarkers do they target? Join Prof. David Hong (Medical Oncologist at MD Anderson Cancer Center, Houston,...

Listen